Skin Aging
If you've been researching options for visible skin aging, you've likely come across terms like PRP, exosomes, or stem cell culture supernatant. This page explains what these approaches are, and aren't, in plain terms.
International Patient Guide →Last reviewed: 2026-07-23

What People Usually Notice
Why It May Happen
What to clarify before considering care in Japan
Some patients explore cell-derived aesthetic formulations — stem cell culture supernatant, autologous PRP, or exosome serums — delivered by micro-injection and matched to a specific skin or scalp concern rather than one fixed protocol. These are intended to help support the appearance of skin quality; they are not positioned as a cure for aging or a guarantee of a specific cosmetic result.
Because these formulations differ meaningfully in composition and regulatory treatment, we describe our own processing conditions plainly and don't rely on unverified certification claims — the same standard described on our Safety & Regulation overview.
Which formulation, if any, may be appropriate is discussed individually during consultation, based on your specific concern and goals — not determined generically by this page.

Related Treatment Options
Regenerative Skin & Scalp Therapy
Cell-derived formulations — stem cell culture supernatant, autologous PRP, and exosome serums — delivered by micro-injection and matched to your specific skin or scalp concern, rather than one fixed protocol for every client.
Biological Age Diagnostics & Longevity Therapy
A biological-age diagnostics panel paired with physician-directed longevity protocols — NAD+ IV therapy, hormone optimization — designed to identify where intervention may help before symptoms appear, not to promise a fixed outcome.
Autologous PRP Treatment Coordination
A practical route for international patients who want to discuss platelet-rich plasma options for a joint, soft-tissue, scalp, or aesthetic concern with a receiving physician in Japan.
International Patient Journey
Continue Reading
Practical planning questions related to this topic.
Risks & Limitations
No specific cosmetic outcome is guaranteed, and results are not the same for every patient.
These treatments do not reverse the aging process — they are intended to support the appearance of skin quality, not to stop or undo aging.
Candidacy and formulation choice are confirmed individually; not every formulation is appropriate for every patient or concern.
Individual response varies with skin type, age, and treatment goals.
Minor risks are possible with any micro-injection procedure, including localized redness, swelling, or bruising at the treatment site.
Frequently Asked Questions
No. These treatments are intended to help support the appearance of skin quality — they do not reverse the aging process.
No specific cosmetic outcome is guaranteed. Individual response varies, and your practitioner discusses what's realistically achievable during consultation.
They're different formulation types with different compositions and price points. Our Regenerative Aesthetics treatment page explains each in more detail.
Candidacy is confirmed individually, not assumed for every skin type or concern — your practitioner reviews this during consultation.
Many sessions are completed the same day, though a recommended course may involve several sessions spaced weeks apart — your practitioner proposes a specific plan for your case, not a fixed number for everyone.
Let us understand the case before anyone recommends a plan.
Share your goals, medical background, and travel window. StemCellor will help organize the next step around physician review, realistic expectations, timing, and reference cost.
Direct messaging channels are still being confirmed — for now, start through the international patient guide.

Send the main concern, treatment goals, and any medical history that may affect candidacy.
We help clarify which treatment area may be worth discussing before travel is planned.
When appropriate, the case is prepared for physician review and visit planning in Japan.